South Korea Artificial Intelligence In Cancer Diagnostics Market Size & Outlook
- Healthcare IT
- AI in Healthcare
- Artificial Intelligence In Cancer Diagnostics Market Outlook
- AI in Healthcare
Global Market
Related Markets
Ask Prism AI about the artificial intelligence in cancer diagnostics market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
South Korea artificial intelligence in cancer diagnostics market highlights
- The South Korea artificial intelligence in cancer diagnostics market generated a revenue of USD 5.7 million in 2025 and is expected to reach USD 35.7 million by 2033.
- The South Korea market is expected to grow at a CAGR of 25.8% from 2026 to 2033.
- In terms of segment, software was the largest revenue generating component in 2025.
- Services is the most lucrative component segment registering the fastest growth during the forecast period.
Artificial intelligence in cancer diagnostics market data book summary
| Market revenue in 2025 | USD 5.7 million |
| Market revenue in 2033 | USD 35.7 million |
| Growth rate | 25.8% (CAGR from 2026 to 2033) |
| Largest segment | Software |
| Fastest growing segment | Services |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Hardware, Services |
| Key market players worldwide | Microsoft Corp, Roche Holding AG, Quest Diagnostics Inc, Medial EarlySign, CancerCenter.AI, Therapixel, Tempus, Kheiron, SkinVision |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.7% of the global artificial intelligence in cancer diagnostics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China artificial intelligence in cancer diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- South Korea is the fastest growing regional market in Asia Pacific and is projected to reach USD 35.7 million by 2033.
South Africa provides a lucrative opportunity to leverage AI due to its large population and serious institutional shortfalls. The use of AI in healthcare is expected to expedite the development of solutions to major problems such as low quality of education and access to healthcare in African countries.
The opportunities for using AI in healthcare in South Africa are numerous, and there are fewer governing bottlenecks regarding patient data secrecy in comparison with other regions. In recent years, the number of people suffering from cancer has increased substantially in South Africa.
The COVID-19 pandemic and recent technological advancements enabled the country to develop solutions, including AI, with the potential to overcome physical limitations of capital & labor, as well as open up new sources of value & growth. Increasing use of AI in diagnostics can support the negation of inefficiencies such as misdiagnoses and shortage of radiologists in the country.
No credit card required*
Publish Date: Jun 22, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Intelligence In Cancer Diagnostics Market Scope
Artificial Intelligence In Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Microsoft Corp | View profile | 221,000 | One Microsoft Way, Redmond, WA, United States, 98052-6399 | www.microsoft.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| Medial EarlySign | View profile | 11-50 | Hod Hasharon, HaMerkaz, Israel, Asia | earlysign.com/ |
| CancerCenter.AI | View profile | 11-50 | Wroclaw, Dolnoslaskie, Poland, Europe | cancercenter.ai |
| Therapixel | View profile | 11-50 | Nice, Provence-Alpes-Cote d'Azur, France, Europe | www.therapixel.com/ |
| Tempus | View profile | 501-1000 | Chicago, Illinois, United States, North America | www.tempus.com |
| Kheiron | View profile | 11-50 | London, England, United Kingdom, Europe | www.kheironmed.com/ |
| SkinVision | View profile | 11-50 | Amsterdam, Noord-Holland, The Netherlands, Europe | skinvision.com |
South Korea Artificial Intelligence In Cancer Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Artificial Intelligence In Cancer Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 61.4% in 2025.
Horizon Databook has segmented the South Korea artificial intelligence in cancer diagnostics market based on software, hardware, services covering the revenue growth of each sub-segment from 2021 to 2033.
South Africa provides a lucrative opportunity to leverage AI due to its large population and serious institutional shortfalls. The use of AI in healthcare is expected to expedite the development of solutions to major problems such as low quality of education and access to healthcare in African countries.
The opportunities for using AI in healthcare in South Africa are numerous, and there are fewer governing bottlenecks regarding patient data secrecy in comparison with other regions. In recent years, the number of people suffering from cancer has increased substantially in South Africa.
The COVID-19 pandemic and recent technological advancements enabled the country to develop solutions, including AI, with the potential to overcome physical limitations of capital & labor, as well as open up new sources of value & growth. Increasing use of AI in diagnostics can support the negation of inefficiencies such as misdiagnoses and shortage of radiologists in the country.
- South Korea Artificial Intelligence In Cancer Diagnostics Market Component Outlook (Revenue, USD Million , 2021-2033)
- Software
- Hardware
- Services
- South Korea Artificial Intelligence In Cancer Diagnostics Market Cancer Type Outlook (Revenue, USD Million , 2021-2033)
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
- Others
- Breast Cancer
- Brain Tumor
- South Korea Artificial Intelligence In Cancer Diagnostics Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospital
- Surgical Centers and Medical Institutes
- Others
Reasons to subscribe to Artificial Intelligence In Cancer Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Artificial Intelligence In Cancer Diagnostics Market Outlook databook
- Our clientele includes a mix of Artificial Intelligence In Cancer Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea Artificial Intelligence In Cancer Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Korea Artificial Intelligence In Cancer Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
South Korea Artificial Intelligence In Cancer Diagnostics Market, 2021-2033 (US$M)
South Korea artificial intelligence in cancer diagnostics market statistics, by component, 2021-2033 (US$M)
